文化大學機構典藏 CCUR:Item 987654321/35878
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 46833/50693 (92%)
Visitors : 11847373      Online Users : 527
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/35878


    Title: Activin A Predicts Left Ventricular Remodeling and Mortality in Patients with ST-Elevation Myocardial Infarction
    Authors: Lin, JF (Lin, Jeng-Feng)
    Hsu, SY (Hsu, Shun-Yi)
    Teng, MS (Teng, Ming-Sheng)
    Wu, S (Wu, Semon)
    Hsieh, CA (Hsieh, Chien-An)
    Jang, SJ (Jang, Shih-Jung)
    Liu, CJ (Liu, Chih-Jen)
    Huang, HL (Huang, Hsuan-Li)
    Ko, YL (Ko, Yu-Lin)
    Contributors: 生科系
    Keywords: Activin A
    Acute myocardial infarction
    Left ventricular remodeling
    Date: 2016-07
    Issue Date: 2017-04-12 15:45:29 (UTC+8)
    Abstract: Background: Activin A levels increase in a variety of heart diseases including ST-elevation myocardial infarction (STEMI). The aim of this study is to investigate whether the level of activin A can be beneficial in predicting left ventricular remodeling, heart failure, and death in patients with ST-elevation myocardial infarction (STEMI).

    Methods: We enrolled 278 patients with STEMI who had their activin A levels measured on day 2 of hospitalization. Echocardiographic studies were performed at baseline and were repeated 6 months later. Thereafter, the clinical events of these patients were followed for a maximum of 3 years, including all-cause death and readmission for heart failure.

    Results: During hospitalization, higher activin A level was associated with higher triglyceride level, lower left ventricular ejection fraction (LVEF), and lower left ventricular end diastolic ventricular volume index (LVEDVI) in multivariable linear regression model. During follow-up, patients with activin A levels > 129 pg/ml had significantly lower LVEF, and higher LVEDVI at 6 months. Kaplan-Meier survival curves showed that activin A level > 129 pg/ml was a predictor of all-cause death (p = 0.022), but not a predictor of heart failure (p = 0.767).

    Conclusions: Activin A level > 129 pg/ml predicts worse left ventricular remodeling and all -cause death in STEMI.
    Relation: ACTA CARDIOLOGICA SINICA 卷: 32 期: 4 頁碼: 420-427
    Appears in Collections:[Department of Biology ] journal articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML476View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback